Clinical trial
Upper Extremity Injection of Xeomin® and Changes in Gait Related Mobility in Adults After Stroke
NCT04908423 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Upper Extremity Injection of Xeomin® and Changes in Gait Related Mobility in Adults After Stroke
- Lead sponsor
- Wake Forest University Health Sciences
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- October 19, 2021
- Completion date
- April 30, 2027
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.